Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AbCellera Biologics Inc (ABCL) vs Icl Group Ltd (ICL) Price & Performance

AbCellera Biologics IncTrade
Icl Group LtdTrade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs Icl Group Ltd — how do they compare? AbCellera Biologics Inc trades at $9.23 (market cap $2.99B), while Icl Group Ltd trades at $5.45 (market cap $6.94B). The key difference: Icl Group Ltd is far larger — about 2.3× AbCellera Biologics Inc's market cap, and Icl Group Ltd pays a 3.86% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.

ABCLICL
Market Cap
$2.99B$6.94B
Sector
HealthBasic Materials
52-Week High
$9.76$6.84
52-Week Low
$2.78$4.80
Enterprise Value
$2.58B$9.58B
Dividend Yield
3.86%

Returns comparison

Trailing returns across standard periods

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Read more on ABCL

About Icl Group Ltd

ICL Group Ltd is a manufacturer of products based on minerals. The firm is comprised of four segments: phosphate solutions, potash, industrial products, and innovative agriculture solutions (IAS). These segments all contribute to the company's development of agriculture, food, and engineered material products and services. The company mines and manufactures potash and phosphates to be used as ingredients in fertilizers and serve as a component in the pharmaceutical and food additives industries. It is also engaged in industrial additives and materials, including flame retardants, phosphate salts, specialty phosphate blends, purified phosphoric acid, electronic-grade specialty phosphoric acids. Its geographical segments are Europe, Asia, North & South America, and the Rest of the world.

Read more on ICL